Cargando…

Macrophages Upregulate Estrogen Receptor Expression in the Model of Obesity-Associated Breast Carcinoma

Breast cancer (BC) and obesity are two heterogeneous conditions with a tremendous impact on health. BC is the most commonly diagnosed neoplasm and the leading cause of cancer-related mortality among women, and the prevalence of obesity in women worldwide reaches pandemic proportions. Obesity is a si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nahmias Blank, Daniela, Hermano, Esther, Sonnenblick, Amir, Maimon, Ofra, Rubinstein, Ariel M., Drai, Emmy, Maly, Bella, Vlodavsky, Israel, Popovtzer, Aron, Peretz, Tamar, Meirovitz, Amichay, Elkin, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496942/ https://www.ncbi.nlm.nih.gov/pubmed/36139419 http://dx.doi.org/10.3390/cells11182844

Ejemplares similares

Heparanase augments insulin receptor signaling in breast carcinoma
por: Goldberg, Rachel, et al.
Publicado: (2016)

Regulation of Heparanase in Diabetes-Associated Pancreatic Carcinoma
por: Goldberg, Rachel, et al.
Publicado: (2019)

Radiation-Induced Nephropathy in the Murine Model Is Ameliorated by Targeting Heparanase
por: Abecassis, Alexia, et al.
Publicado: (2023)

Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma
por: Binder Gallimidi, Adi, et al.
Publicado: (2017)

Induction of heparanase by HPV E6 oncogene in head and neck squamous cell carcinoma
por: Hirshoren, Nir, et al.
Publicado: (2014)

Prognostic Factors in Advanced Adrenocortical Carcinoma: Summary of a National Referral Center’s 20 years of Experience
por: Arnon, Johnathan, et al.
Publicado: (2022)

Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice
por: Gil, Natali, et al.
Publicado: (2012)

Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer
por: Zahavi, Tamar, et al.
Publicado: (2021)

Calcitonin Non-Secreting Mixed Medullary-Papillary Thyroid Carcinoma: Report of a Rare Entity and Therapeutic Implications
por: Oleinikov, Kira, et al.
Publicado: (2021)

“High-Risk Breast Cancer Screening in BRCA1/2 Carriers Leads to Early Detection and Improved Survival After a Breast Cancer Diagnosis”
por: Shraga, Shay, et al.
Publicado: (2021)

Cytokines levels, Severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer - a prospective pilot study
por: Meirovitz, Amichay, et al.
Publicado: (2010)

Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study
por: Rotem, Ofer, et al.
Publicado: (2023)

Breast Cancer with Low Recurrence Score on Oncotype DX(©): Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation
por: Zarbiv, Yonaton, et al.
Publicado: (2022)

Impact of Heparanase and the Tumor Microenvironment on Cancer Metastasis and Angiogenesis: Basic Aspects and Clinical Applications
por: Vlodavsky, Israel, et al.
Publicado: (2011)

Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance
por: Alkhatib, Heba, et al.
Publicado: (2022)

A Rare Case of Cutaneous Metastasis of Bladder Transitional Cell Carcinoma
por: Fachler, Tahel, et al.
Publicado: (2021)

Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes
por: Maoz, Myriam, et al.
Publicado: (2019)

Author Correction: Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes
por: Maoz, Myriam, et al.
Publicado: (2020)

Overcoming resistance to EGFR monotherapy in HNSCC by identification and inhibition of individualized cancer processes
por: Jubran, Maria R., et al.
Publicado: (2022)

Newly Generated Heparanase Knock-Out Mice Unravel Co-Regulation of Heparanase and Matrix Metalloproteinases
por: Zcharia, Eyal, et al.
Publicado: (2009)

SYK expression level distinguishes control from BRCA1-mutated lymphocytes
por: Zahavi, Tamar, et al.
Publicado: (2018)

Heparanase expression upregulates platelet adhesion activity and thrombogenicity
por: Cui, Hao, et al.
Publicado: (2016)

Splicing Factor Transcript Abundance in Saliva as a Diagnostic Tool for Breast Cancer
por: Bentata, Mercedes, et al.
Publicado: (2020)

Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model
por: Zahavi, Tamar, et al.
Publicado: (2015)

Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA Mutations
por: Arnon, Johnathan, et al.
Publicado: (2023)

Multimodality Treatment for Advanced Cervical Cancer With Isolated Metastasis to Interventricular Septum of the Heart
por: Shapira-Daniels, Ayelet, et al.
Publicado: (2020)

Endovascular brachytherapy for extensive right-heart and pulmonary artery sarcoma – a case report
por: Aviel, Gal, et al.
Publicado: (2019)

Antibody Delivery into the Brain by Radiosensitizer Nanoparticles for Targeted Glioblastoma Therapy
por: Gal, Omer, et al.
Publicado: (2022)

Novel high dose rate lip brachytherapy technique to improve dose homogeneity and reduce toxicity by customized mold
por: Feldman, Jon, et al.
Publicado: (2014)

Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT)
por: Chicheportiche, Alexandre, et al.
Publicado: (2018)

Dermatomyositis Associated with Lung Cancer: A Brief Review of the Current Literature and Retrospective Single Institution Experience
por: Shalata, Walid, et al.
Publicado: (2022)

Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study
por: Reuveni, Tobi, et al.
Publicado: (2011)

Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients
por: Zick, Aviad, et al.
Publicado: (2017)

Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient management
por: Chicheportiche, Alexandre, et al.
Publicado: (2020)

Transurethral Prostatectomy Before or After External Beam Radiotherapy: Complications and Reoperation Rates
por: Molineros, Gabriel, et al.
Publicado: (2021)

A new method for cancer detection based on diffusion reflection measurements of targeted gold nanorods
por: Ankri, Rinat, et al.
Publicado: (2012)

Potential Refinement of Recurrence Score by pSTAT3 Status
por: Grinshpun, Albert, et al.
Publicado: (2022)

Predictive power of the post-treatment scans after the initial or first two courses of [(177)Lu]-DOTA-TATE
por: Chicheportiche, Alexandre, et al.
Publicado: (2018)

Modified bi‐weekly cetuximab‐cisplatin and 5‐FU/leucovorin based regimen for effective treatment of recurrent/metastatic head and neck squamous cell carcinoma to reduce chemotherapy exposure of patients
por: Meirovitz, Amichay, et al.
Publicado: (2021)

Long-Lasting Therapeutic Response following Treatment with Pembrolizumab in Patients with Non-Small Cell Lung Cancer: A Real-World Experience
por: Shalata, Walid, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8hppogom2in9esqetl3pori153